Does Low-level Laser Therapy Protocol Affect the Efficacy of Treatment of Inferior Alveolar Nerve Injury After Maxillofacial Surgery
Launched by KARADENIZ TECHNICAL UNIVERSITY · Mar 24, 2025
Trial Information
Current as of June 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with unilateral or bilateral inferior alveolar nerve damage caused by maxillofacial surgery and receiving DESL treatment
- • 2. Patients with a follow-up period of at least 6 months
- • 3. Patients whose diagnosis has been confirmed by clinical neurosensory testing
- • 4. Patients with complete study data and follow-up
- • 5. Patients who have not previously undergone any microsurgical or conservative treatment in the head and neck region due to nerve damage
- • 6. Patients without known neurological disease that may affect the study results
- • 7. Patients without active infection (pain, temperature increase, redness, edema, loss of function, etc.) or pathological findings (tumour, cyst, etc.) in the relevant area were included.
- Exclusion Criteria:
- • 1. Patients with nerve damage due to other reasons (pathology, infection, etc.) before maxillofacial surgery
- • 2. Patients with lingual nerve damage
- • 3. Patients with known neurological disease that may affect the study results
- • 4. Patients with missing data or patients who cannot be followed up
- • 5. Pregnant patients were not included in the study.
About Karadeniz Technical University
Karadeniz Technical University is a prestigious academic institution located in Trabzon, Turkey, renowned for its commitment to advancing research and education in the fields of science and technology. As a clinical trial sponsor, the university leverages its extensive resources, expertise, and collaborative networks to conduct innovative research that enhances healthcare outcomes. With a focus on ethical standards and rigorous methodologies, Karadeniz Technical University aims to contribute valuable insights to medical science and improve patient care through well-designed clinical studies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trabzon, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported